Tang C, Han H, Liu Z, Liu Y, Yin L, Cai J, He L, Chen G, Zhang Z, Yin XM, et al. Activation of BNIP3-mediated mitophagy protects against renal ischemia-reperfusion injury. Cell Death Dis. 2019;10(9):019–1899.

Article  Google Scholar 

Jun W, Benjanuwattra J, Chattipakorn SC, Chattipakorn N. Necroptosis in renal ischemia/reperfusion injury: A major mode of cell death? Arch Biochem Biophys. 2020;689(108433):26.

Google Scholar 

Ikeda M, Prachasilchai W, Burne-Taney MJ, Rabb H, Yokota-Ikeda N. Ischemic acute tubular necrosis models and drug discovery: a focus on cellular inflammation. Drug Discov Today. 2006;11(7–8):364–70.

Article  CAS  PubMed  Google Scholar 

Han SJ, Lee HT. Mechanisms and therapeutic targets of ischemic acute kidney injury. Kidney Res Clin Pract. 2019;38(4):427–40.

Article  PubMed  PubMed Central  Google Scholar 

Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380(9843):756–66.

Article  PubMed  Google Scholar 

Zuk A, Bonventre JV. Acute Kidney Injury. Annu Rev Med. 2016;67:293–307.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol. 2008;109(4):18.

Article  Google Scholar 

Liu H, Wang L, Weng X, Chen H, Du Y, Diao C, Chen Z, Liu X. Inhibition of Brd4 alleviates renal ischemia/reperfusion injury-induced apoptosis and endoplasmic reticulum stress by blocking FoxO4-mediated oxidative stress. Redox Biol. 2019;24(101195):11.

Google Scholar 

Havasi A, Borkan SC. Apoptosis and acute kidney injury. Kidney Int. 2011;80(1):29–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiao C, Zhao H, Zhu H, Zhang Y, Su Q, Zhao F, Wang R. Tisp40 induces tubular epithelial cell GSDMD-mediated pyroptosis in renal ischemia-reperfusion injury via NF-κB signaling. Front Physiol. 2020;11:906.

Article  PubMed  PubMed Central  Google Scholar 

Poon GMK, Kim HM. Signatures of DNA target selectivity by ETS transcription factors. Transcription. 2017;8(3):193–203.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharrocks AD. The ETS-domain transcription factor family. Nat Rev Mol Cell Biol. 2001;2(11):827–37.

Article  CAS  PubMed  Google Scholar 

Suico MA, Shuto T, Kai H. Roles and regulations of the ETS transcription factor ELF4/MEF. J Mol Cell Biol. 2017;9(3):168–77.

CAS  PubMed  PubMed Central  Google Scholar 

Miyazaki Y, Sun X, Uchida H, Zhang J, Nimer S. MEF, a novel transcription factor with an Elf-1 like DNA binding domain but distinct transcriptional activating properties. Oncogene. 1996;13(8):1721–9.

CAS  PubMed  Google Scholar 

Lacorazza HD, Yamada T, Liu Y, Miyata Y, Sivina M, Nunes J, Nimer SD. The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells. Cancer Cell. 2006;9(3):175–87.

Article  CAS  PubMed  Google Scholar 

Yamada T, Park CS, Mamonkin M, Lacorazza HD. Transcription factor ELF4 controls the proliferation and homing of CD8+ T cells via the Krüppel-like factors KLF4 and KLF2. Nat Immunol. 2009;10(6):618–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lacorazza HD, Miyazaki Y, Di Cristofano A, Deblasio A, Hedvat C, Zhang J, Cordon-Cardo C, Mao S, Pandolfi PP, Nimer SD. The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. Immunity. 2002;17(4):437–49.

Article  CAS  PubMed  Google Scholar 

Lee PH, Puppi M, Schluns KS, Yu-Lee LY, Dong C, Lacorazza HD. The transcription factor E74-like factor 4 suppresses differentiation of proliferating CD4+ T cells to the Th17 lineage. J Immunol. 2014;192(1):178–88.

Article  CAS  PubMed  Google Scholar 

Du H, Xia H, Liu T, Li Y, Liu J, Xie B, Chen J, Cao L, Liu S, Li S, et al. Suppression of ELF4 in ulcerative colitis predisposes host to colorectal cancer. iScience. 2021;24(3):19.

Article  Google Scholar 

Tyler PM, Bucklin ML, Zhao M, Maher TJ, Rice AJ, Ji W, Warner N, Pan J, Morotti R, McCarthy P, et al. Human autoinflammatory disease reveals ELF4 as a transcriptional regulator of inflammation. Nat Immunol. 2021;22(9):1118–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Funk JA, Schnellmann RG. Accelerated recovery of renal mitochondrial and tubule homeostasis with SIRT1/PGC-1α activation following ischemia-reperfusion injury. Toxicol Appl Pharmacol. 2013;273(2):345–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li M, Ning J, Huang H, Jiang S, Zhuo D. Allicin protects against renal ischemia-reperfusion injury by attenuating oxidative stress and apoptosis. Int Urol Nephrol. 2022;54(7):1761–8.

Article  CAS  PubMed  Google Scholar 

Maicas N, van der Vlag J, Bublitz J, Florquin S, Bakker-van Bebber M, Dinarello CA, Verweij V, Masereeuw R, Joosten LA, Hilbrands LB. Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury. PLoS One. 2017;12(2):e0168981.

Article  PubMed  PubMed Central  Google Scholar 

Forni LG, Darmon M, Ostermann M, Oudemans-van Straaten HM, Pettilä V, Prowle JR, Schetz M, Joannidis M. Renal recovery after acute kidney injury. Intensive Care Med. 2017;43(6):855–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lameire NH, Bagga A, Cruz D, De Maeseneer J, Endre Z, Kellum JA, Liu KD, Mehta RL, Pannu N, Van Biesen W, et al. Acute kidney injury: an increasing global concern. Lancet. 2013;382(9887):170–9.

Article  PubMed  Google Scholar 

Rewa O, Bagshaw SM. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol. 2014;10(4):193–207.

Article  CAS  PubMed  Google Scholar 

Nazir S, Gadi I, Al-Dabet MM, Elwakiel A, Kohli S, Ghosh S, Manoharan J, Ranjan S, Bock F, Braun-Dullaeus RC, et al. Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibition. Blood. 2017;130(24):2664–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang S, Liu A, Wu G, Ding HF, Huang S, Nahman S, Dong Z. The CPLANE protein Intu protects kidneys from ischemia-reperfusion injury by targeting STAT1 for degradation. Nat Commun. 2018;9(1):018–03628.

Google Scholar 

Kunzendorf U, Haase M, Rölver L, Haase-Fielitz A. Novel aspects of pharmacological therapies for acute renal failure. Drugs. 2010;70(9):1099–114.

Article  CAS  PubMed  Google Scholar 

Li J, Hong Z, Liu H, Zhou J, Cui L, Yuan S, Chu X, Yu P. Hydrogen-rich saline promotes the recovery of renal function after ischemia/reperfusion injury in rats via anti-apoptosis and anti-inflammation. Front Pharmacol. 2016;7:106.

Article  PubMed  PubMed Central  Google Scholar 

Chen L, Markó L, Kaßmann M, Zhu Y, Wu K, Gollasch M. Role of TRPV1 channels in ischemia/reperfusion-induced acute kidney injury. PLoS One. 2014;9(10):e109842.

Article  PubMed  PubMed Central  Google Scholar 

Zhang G, Wang Q, Wang W, Yu M, Zhang S, Xu N, Zhou S, Cao X, Fu X, Ma Z, et al. Tempol protects against acute renal injury by regulating PI3K/Akt/mTOR and GSK3β signaling cascades and afferent arteriolar activity. Kidney Blood Press Res. 2018;43(3):904–13.

Article  CAS  PubMed  Google Scholar 

Xiong C, Zang X, Zhou X, Liu L, Masucci MV, Tang J, Li X, Liu N, Bayliss G, Zhao TC, et al. Pharmacological inhibition of Src kinase protects against acute kidney injury in a murine model of renal ischemia/reperfusion. Oncotarget. 2017;8(19):31238–53.

Article  PubMed  PubMed Central  Google Scholar 

Han WK, Waikar SS, Johnson A, Betensky RA, Dent CL, Devarajan P, Bonventre JV. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008;73(7):863–9.

Article  CAS  PubMed  Google Scholar 

Kuchroo VK, Umetsu DT, DeKruyff RH, Freeman GJ. The TIM gene family: emerging roles in immunity and disease. Nat Rev Immunol. 2003;3(6):454–62.

Article  CAS  PubMed  Google Scholar 

Chen R, Xu H, Guo Z, Zhang P, Chen J, Chen Z. CID16020046, a GPR55 antagonist, attenuates sepsis-induced acute kidney injury. Mol Med Rep. 2022;25(5):4.

Article  PubMed  Google Scholar 

Pickkers P, Ostermann M, Joannidis M, Zarbock A, Hoste E, Bellomo R, Prowle J, Darmon M, Bonventre JV, Forni L, et al. The intensive care medicine agenda on acute kidney injury. Intensive Care Med. 2017;43(9):1198–209.

Article  CAS  PubMed  PubMed Central